Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Int J Dent ; 2021: 6043488, 2021.
Article in English | MEDLINE | ID: mdl-34691182

ABSTRACT

OBJECTIVES: Xerostomia is a subjective sensation of dry mouth. It is commonly associated with salivary gland hypofunction. Both changes in the composition of the saliva and a reduction in the quantity secreted may be an objective finding of dry mouth. Although there are no currently available cures for the conditions resulting in dry mouth, there are several treatment options that give hope for patients who suffer from xerostomia. Individuals with some residual salivary gland function, which are contraindicated to pharmacological therapies, would benefit the most from identifying novel, alternative effective methods for stimulating production of saliva. The aim of this study was to give an overview of the latest and most relevant data related to treatment modalities for the management of dry mouth conditions. Data Resources and Study Selection. The present review was prepared by searching the National Library of Medicine database using the relevant medical terms and their combinations. A total of thirty-three studies met the inclusion criteria. Data were extracted by one author and verified by another. CONCLUSION: A number of patients showed positive treatment outcomes, and the adverse effects of both electrical stimulation (ES) and acupuncture have been reported as mild and transient. In patients who have undergone radiotherapy, acupuncture is shown to increase salivation. However, in patients with Sjogren's syndrome, the effects of ES devices seem to be elusive. Moreover, due to the instability of the findings in relation to longevity of clinical effect, patient satisfaction, quality of life, and clinical effectiveness of such treatments, the results remain vague.

2.
Curr Eye Res ; 46(4): 504-514, 2021 04.
Article in English | MEDLINE | ID: mdl-32777180

ABSTRACT

PURPOSE: Maintaining mature and viable retinal pigment epithelial cells (RPE) in vitro has proven challenging. Investigating compounds that can promote RPE-viability and maturation is motivated by RPE transplantation research, the quest to understand RPE physiology, and a desire to modulate RPE in pathological states. We have previously reported that the silk protein sericin promotes viability, maturation, and pigmentation of human fetal RPE. In the present study, our aim was to uncover whether these effects can be seen in adult retinal pigment epithelial cell line-19 (ARPE-19) and induced pluripotent stem cell-derived RPE (iPSC-RPE). METHODS: ARPE-19 and iPSC-RPE were cultured with or without 10 mg/mL sericin. After 7 days, viability was assessed with calcein-acetoxymethyl ester (CAM) and ethidium homodimer-1 (EH-1) assays, flow cytometry, and morphometric analysis. Expression levels of RPE65, tyrosinase, and Pmel17 were quantified to compare maturation between the sericin-treated and control cultures. Light microscopy and staining of the tight junction protein zonula occludens protein 1 (ZO-1) were employed to study sericin's effects on RPE morphology. We also measured culture medium pH, glucose, lactate, and extracellular ion content. RESULTS: Sericin-supplemented RPE cultures demonstrated significantly better viability compared to control cultures. Sericin appeared to improve ARPE-19 maturation and morphology in vitro. No effects were seen on RPE pigmentation with the concentration of sericin and duration of cell culture herein reported. CONCLUSIONS: This is the first study to demonstrate that supplementing the culture media with sericin promotes the viability of iPSC-RPE and ARPE-19. Sericin's viability-promoting effects may have important implications for retinal therapeutics and regenerative medicine research.


Subject(s)
Induced Pluripotent Stem Cells/drug effects , Retinal Pigment Epithelium/drug effects , Sericins/pharmacology , Cell Line , Cell Survival/physiology , Cells, Cultured , Flow Cytometry , Glucose/metabolism , Humans , Hydrogen-Ion Concentration , Induced Pluripotent Stem Cells/cytology , Induced Pluripotent Stem Cells/metabolism , Lactic Acid/metabolism , Monophenol Monooxygenase/metabolism , Retinal Pigment Epithelium/cytology , Retinal Pigment Epithelium/metabolism , Zonula Occludens-1 Protein/metabolism , cis-trans-Isomerases/metabolism , gp100 Melanoma Antigen/metabolism
3.
Ocul Surf ; 18(4): 583-594, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32629039

ABSTRACT

PURPOSE: To review the published literature related to application of intense pulsed light (IPL) for treating meibomian gland dysfunction (MGD). METHODS: The literature search included the PubMed database and used the keywords "Intense Pulsed Light and Meibomian Gland Dysfunction". RESULTS: IPL is a new instrumental treatment modality for MGD. This treatment modality was originally developed for use in dermatology and was later adopted in ophthalmology for treating MGD. IPL therapy for MGD can improve tear film stability, meibomian gland functionality, as well as subjective feeling of ocular dryness. However, in the reviewed literature, there was great variability in patient selection, evaluation criteria, and treatment protocols and durations. CONCLUSION: Numerous studies report that IPL is effective for treating MGD and a safe procedure. There is great potential for further improvements to the procedure, as large comparative studies employing different treatment modalities are lacking.


Subject(s)
Meibomian Gland Dysfunction , Humans , Intense Pulsed Light Therapy , Meibomian Glands , Ophthalmology , Tears
4.
Invest Ophthalmol Vis Sci ; 61(4): 5, 2020 04 09.
Article in English | MEDLINE | ID: mdl-32271885

ABSTRACT

Purpose: Neurons carry electrical signals and communicate via electrical activities. The therapeutic potential of electrical stimulation (ES) for the nervous system, including the retina, through improvement of cell survival and function has been noted. Here we investigated the neuroprotective and regenerative potential of ES in a mouse model of inherited retinal degeneration. Methods: Rhodopsin-deficient (Rho-/-) mice received one or two sessions of transpalpebral ES or sham treatments for 7 consecutive days. Intraperitoneal injection of 5-ethynyl-2'-deoxyuridine was used to label proliferating cells. Weekly electroretinograms were performed to monitor retinal function. Retinal morphology, photoreceptor survival, and regeneration were evaluated in vivo using immunohistochemistry and genetic fate-mapping techniques. Müller cell (MC) cultures were employed to further define the optimal conditions of ES application. Results: Noninvasive transpalpebral ES in Rho-/- mice improved photoreceptor survival and electroretinography function in vivo. ES also triggered residential retinal progenitor-like cells such as MCs to reenter the cell cycle, possibly producing new photoreceptors, as shown by immunohistochemistry and genetic fate-mapping techniques. ES directly stimulated cell proliferation and the expression of progenitor cell markers in MC cultures, at least partially through bFGF signaling. Conclusions: Our study showed that transpalpebral ES improved photoreceptor survival and retinal function and induced the proliferation, probably photoreceptor regeneration, of MCs; this occurs via stimulation of the bFGF pathways. These results suggest the exciting possibility of applying noninvasive ES as a versatile tool for preventing photoreceptor loss and mobilizing endogenous progenitors for reversing vision loss in patients with photoreceptor degeneration.


Subject(s)
Disease Models, Animal , Electric Stimulation Therapy , Photoreceptor Cells, Vertebrate/cytology , Retinal Degeneration/therapy , Retinal Ganglion Cells/physiology , Animals , Cell Cycle/physiology , Cell Differentiation/physiology , Cell Proliferation/physiology , Cell Survival/physiology , Cells, Cultured , Electroretinography , Ependymoglial Cells , Immunohistochemistry , In Situ Nick-End Labeling , Mice , Mice, Knockout , Retinal Degeneration/genetics , Retinal Degeneration/physiopathology , Rhodopsin/genetics
SELECTION OF CITATIONS
SEARCH DETAIL